Ryan Hanula, BSc; Émilie Bortolussi-Courval, NClin; Arielle Mendel, MD, MSc; et al.
open access
JAMA Intern Med. 2024;184(1):18-27. doi:10.1001/jamainternmed.2023.0699
This meta-analysis assesses the efficacy and safety of oseltamivir in preventing hospitalization among influenza-infected adult and adolescent outpatients.
Health Care Policy and Law
Sarah Batbold, BS; Jennifer D. Duke, MD; Kirsten A. Riggan, MA, MS; et al.
JAMA Intern Med. 2024;184(1):28-35. doi:10.1001/jamainternmed.2023.5794
This qualitative study of medical records examines how decision-making occurs for hospitalized incarcerated persons lacking decisional capacity.
Tou-Yuan Tsai, MD; Yu-Chang Liu, MD; Wan-Ting Huang, MS; et al.
free access
JAMA Intern Med. 2024;184(1):37-45. doi:10.1001/jamainternmed.2023.6160
This Taiwanese cohort study evaluates the risk of bleeding and mortality after alteplase treatment for patients with acute ischemic stroke treated with non–vitamin K antagonist oral anticoagulants (NOACs) vs not treated with NOACs.
Health Care Policy and Law
Leeza Osipenko, PhD; Philippe Potey, PhD; Bernardo Perez, MD; et al.
open access
JAMA Intern Med. 2024;184(1):46-52. doi:10.1001/jamainternmed.2023.6249
This cross-sectional study examines the provenance and clinical benefit of medicines that entered the French market between 2008 and 2018 using the Prescrire and Haute Autorité de Santé grading systems.
Kristine Yaffe, MD; Eric Vittinghoff, PhD; Sascha Dublin, MD, PhD; et al.
free access
JAMA Intern Med. 2024;184(1):54-62. doi:10.1001/jamainternmed.2023.6279
This randomized clinical trial aims to determine if a personalized, multidomain risk-reduction intervention improves cognition and dementia risk profile among adults 70 years and older.
Health Care Policy and Law
Matthew Vogel, MBA; Olivia Zhao, MPhil; William B. Feldman, MD, DPhil, MPH; et al.
free access
JAMA Intern Med. 2024;184(1):63-69. doi:10.1001/jamainternmed.2023.6293
This cross-sectional study examines the costs of the exemption from Medicare price negotiation under the Inflation Reduction Act (IRA) for drugs approved solely for the treatment of a single rare disease.
Érica da Silva Carvalho, MSc; Andrea Renata do Nascimento Souza, MSc; Dessana Francis Chehuan Melo, MD; et al.
open access
JAMA Intern Med. 2024;184(1):70-80. doi:10.1001/jamainternmed.2023.6538
This randomized clinical trial investigates the feasibility, safety, and efficacy of low-level laser therapy in reducing the local manifestations of Bothrops atrox envenomations.
W. James Deardorff, MD; Sun Y. Jeon, PhD; Deborah E. Barnes, PhD, MPH; et al.
JAMA Intern Med. 2024;184(1):81-91. doi:10.1001/jamainternmed.2023.6548
This prognostic study leverages 2 nationally representative prospective cohorts, the Health and Retirement Study and the National Health and Aging Trends Study, to develop and validate models to predict need for nursing home level of care among older adults with probable dementia.